Acquiring Company
Bora Pharmaceuticals Ltd
Acquired Company
MacroGenics
Taipei
RockvilleManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Bora Pharmaceuticals has completed the acquisition of MacroGenics' GMP drug substance manufacturing operations for $122.5 million. As part of the deal, Bora assumes responsibility for manufacturing and has hired around 140 employees from MacroGenics. The acquisition includes MacroGenics' Rockville manufacturing site and a supply agreement for future needs. This strategic move aims to enhance Bora's capabilities in pharmaceutical manufacturing.
Quick answer
Bora Pharmaceuticals Ltd is acquiring MacroGenics, announced July 2, 2026. Bora Pharmaceuticals Ltd is based in Taipei, Taipei City, Taiwan.
- How much did Bora Pharmaceuticals Ltd pay for MacroGenics?
- The deal value was not disclosed.
- What does Bora Pharmaceuticals Ltd do?
- Bora Pharmaceuticals Co., Ltd. is a multinational pharmaceutical company that focuses on expanding its rare disease portfolio through strategic acquisitions.
- Where are Bora Pharmaceuticals Ltd and MacroGenics based?
- Bora Pharmaceuticals Ltd is based in Taipei, Taipei City, Taiwan. MacroGenics is based in Rockville, Maryland, United States.
- Who are the decision-makers at Bora Pharmaceuticals Ltd?
- Fundz holds 5 contacts at Bora Pharmaceuticals Ltd. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Gilead Sciences to acquire MacroGenics for $1.7B, $1.7B (May 19, 2026)
- Jazz Pharmaceuticals acquires Actio Biosciences (August 10, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
Who to call at Bora Pharmaceuticals Ltd, and when
When Bora Pharmaceuticals Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Bora Pharmaceuticals Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bora Pharmaceuticals Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bora Pharmaceuticals Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bora Pharmaceuticals Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired MacroGenics?
MacroGenics was acquired by Bora Pharmaceuticals Ltd, based in Taipei. The deal was reported on July 2, 2026. Bora Pharmaceuticals Co., Ltd. is a multinational pharmaceutical company that focuses on expanding its rare disease portfolio through strategic acquisitions. Bora Pharmaceuticals Ltd is publicly traded (BORAY) and operates in Manufacturing.
When did Bora Pharmaceuticals Ltd acquire MacroGenics?
Bora Pharmaceuticals Ltd's acquisition of MacroGenics was reported on July 2, 2026. Bora Pharmaceuticals has completed the acquisition of MacroGenics' GMP drug substance manufacturing operations for $122.5 million. As part of the deal, Bora assumes responsibility for manufacturing and has hired around 140 employees from MacroGenics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MacroGenics do?
MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. It is publicly traded (MGNX), operating in Manufacturing, and is based in Rockville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.